Eli Lilly begins first human tests of an antibody drug against Covid-19
The medicine, a man-made antibody against the coronavirus that causes the disease, was discovered by a Vancouver company.
Related Articles
Covid ignited a global controversy over what is an airborne disease. The WHO just expanded its definition
A WHO advisory committee outlined a new set of definitions that more accurately reflect the science of airborne disease transmission.
Dana-Farber retracts string of studies in systematic review of data integrity
“It is good to see this institution taking a harder stance against sloppy science and intentional data falsification that many institutes have done in the…
Dana-Farber retracts string of studies in systematic review of data integrity
“It is good to see this institution taking a harder stance against sloppy science and intentional data falsification that many institutes have done in the…
A Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression – PubMed
A Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression
Microsoft is selling AI in health care, and helping to set its standards. Is that a problem?
For some, Microsoft’s deep involvement in setting standards for the use of AI in health care raises questions about “regulatory capture.”
ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs
After scouring 200 companies’ pipelines, a new biotech firm is launching with one of the most wide-ranging pipelines yet for obesity drug development.
Former HHS secretaries: Congress should adopt site-neutral payments for health care
Imagine that your favorite independent coffee shop is bought by a global chain. Your $2 cup of joe jumps to $4 overnight. That’s essentially what’s…
Microsoft is selling AI in health care, and helping to set its standards. Is that a problem?
For some, Microsoft’s deep involvement in setting standards for the use of AI in health care raises questions about “regulatory capture.”
How BIO CEO’s cozy relationship with WuXi soured
As lawmakers take aim at WuXi Apptec, the issue is testing the ability of BIO’s CEO to navigate a domestic policy issue that is tangled…
23andme CEO Anne Wojcicki moves to take company private
After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private.